Bethesda, MD - This FASEB Science Research Conference "Lysophospholipid and Related Mediators - From Bench to Clinic" focuses mainly on new developments in understanding the biology of lysophospholipids, especially lysophosphosphatidate (LPA) and sphingosine 1-phosphate. Lysophospholipids activate families of G protein-coupled receptors and they also have intracellular actions. Dysfunctions of lysophospholipid signaling cause defects in embryological development, wound repair, inflammation, fibrosis, malfunction in the vascular and immune systems, and tumor progression, metastasis and chemo-resistance. The conference will discuss recent scientific advances in understanding how lysophospholipids control normal physiological signaling. These sessions will be followed by discussions on how this signaling becomes dysfunctional in a variety of clinical conditions. There will also be presentations on the new medical treatments that have been initiated to translate this knowledge into clinical practice. There will be significant representation from the pharmaceutical industry in order to facilitate networking between industry and academia. Several new therapeutic developments in this area will be highlighted during the meeting. The overall purpose of the conference is to disseminate new knowledge concerning lysophospholipid and related lipid biology in health and disease with a focus on translational developments into the clinic. The topic areas have been chosen to maximize discussion of provocative and important developments.
We have left up to 32 speaking slots open and these will be selected from novel advances during 2014-2015 and from the abstracts that have been submitted. We intend to hold two different poster sessions during the conference and these will each be open for two days. Time will also be allocated to two "meet the expert sessions" where the invited speakers will dedicate time to interacting with trainees and give advice concerning the science and possible prospects for postdoctoral training or other employment. The conference will allow ample time for principal investigators and trainees to interact and talk with the invited speakers, who are expected to attend each day of the meeting.
This FASEB conference has taken place every two years since 1999. It has become a very popular conference and it consistently attracts leading experts from within the field. We hope that this year will be no exception and that the conference will be all the more attractive since it will be held in spectacular scenery in the Canadian Rocky Mountains.
FASEB has announced a total of 34 Science Research Conferences (SRC) in 2015. Registration opens January 20, 2015. For more information about an SRC, view preliminary programs, or find a listing of all our 2015 SRCs, please visit http://www.
Since 1982, FASEB SRC has offered a continuing series of inter-disciplinary exchanges that are recognized as a valuable complement to the highly successful society meetings. Divided into small groups, scientists from around the world meet intimately and without distractions to explore new approaches to those research areas undergoing rapid scientific changes.
In efforts to expand the SRC series, potential organizers are encouraged to contact SRC staff at SRC@faseb.org. Proposal guidelines can be found at http://www.
FASEB is composed of 27 societies with more than 120,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.
Federation of American Societies for Experimental Biology
9650 Rockville Pike, Bethesda, MD 20814-3998
LYSOPHOSPHOLIPID AND RELATED MEDIATORS - FROM BENCH TO CLINIC
Date: August 23-28, 2015, Banff, Canada
Organizers: David Brindley, Denise Hemmings, Susan Pyne, Nigel Pyne